Member Info for maximillion69

Https://www.linkedin.com/posts/mahle-powertrain_hydrogen-ammonia-netzero-activity-7338170219896455168-mmd2?utm_source=share&utm_medium=member_ios&rcm=ACoAAAkyjQ0B7bMMkoLn8XD8s2HLk9vizWE-zfc

Https://tools.abtdomain.com/domain/whois/

Ibailtd.com new registration ?

Https://www.linkedin.com/posts/mrendall_combustionaf-hvac-sustainability-activity-7337061596868870144-IH9A?utm_source=share&utm_medium=member_ios&rcm=ACoAAAkyjQ0B7bMMkoLn8XD8s2HLk9vizWE-zfc

Https://x.com/imgbiometrics/status/1930977519684952537?s=46

Https://x.com/imgbiometrics/status/1930735430875439198?s=46

Dr Lawrence R. Bernstein (Gallixa ) is inventor of GaM and co-investigator in GAM trial

Https://x.com/imgbiometrics/status/1929925541429194820?s=46

That was quick ! 😂😂

With Imaging Biometrics in the title 😄

Great to see Kathleen Schmainda presenting here .

https://www.eventbrite.com/e/brain-tumor-biotech-summit-2025-tickets-1311919670049

Https://www.glioblastomamultiforme.it/en/research-news-in-the-second-two-months-of-2025/

Fell

It gets picked up every year , not likely the company buying at the moment. Ironically our CEO sold the lot also ironically in recent BRH RNS he touted to hot to sell !!!

Let us know when you can work it all out !

Out with IQAI in with Imaging Biometrics ! Maybe new website after AGM .

Https://x.com/iqai_ib/status/1924971608604631096?s=46

Tyke

TB has managed to repost a few X posts of late !

👀

Https://x.com/iqai_ib/status/1924815905667575808?s=46

Https://x.com/iqai_ib/status/1924530757969514889?s=46

Https://x.com/iqai_ib/status/1924157054639333703?s=46

Tyke

It will be IB that will be bought out not Iqai .

Good weekend !

Explore our exciting lineup of presentations at this year's American Society of Neuroradiology Annual Meeting.

Schedule a Time to meet with us or stop by booth 418.

Oral Presentations

🔹 Potent In Vivo Efficacy of the Novel Iron Mimetic Gallium Maltolate for the Treatment of Primary Brain Tumors

Mona Al-Gizawiy, Robert Wujek, Kyle Johnson, Jason Sidabras, Melissa Prah, Jennifer Connelly, Christopher Chitambar, Kathleen Schmainda

🔹 Fractional Tumor Burden Accurately Informs Surgical Biopsy Target

Melissa A. Prah, Max O. Krucoff, Kathleen M. Schmainda

Electronic Poster Presentations

📌 Delta T1 (DT1) Maps for the Determination of Ablation Extent After Laser Interstitial Thermal Therapy (LITT)

Kathleen Schmainda, Melissa A. Prah, Felicity Giampietro, Max Krucoff

📌 Fractional Tumor Burden (FTB) Mapping Helps to Monitor Glioblastoma Progression in the Clinical Trial of Gallium Maltolate: Case Report

Casey J. Zoss, Melissa A. Prah, Christopher R. Chitambar, MD, Jennifer M. Connelly, MD, Kathleen Schmainda, PhD

📌 Fractional Tumor Burden (FTB): An Early Predictor of Response to Tumor Treating Fields (TTFields) in Glioblastoma

Kathleen M. Schmainda, Melissa A. Prah, Jennifer Connelly

📌 Automated FTB Maps: Quantitative Assessment of Brain Tumor Burden

Michael Schmainda